Pre-clinical studies till date suggest that combination therapy with TRAIL and chemotherapeutic drugs, natural compounds, or radiation is undoubtedly a logical way forwards in devising rationalized therapeutic regimens for TRAIL resistant cancers. Here, TNFSF10 is linked to cancer.